In a City of Hope study recently published in the journal PLOS One, researchers found that people successfully vaccinated against hepatitis B had a 33 percent drop in diabetes risk when compared to people who had not received the vaccine. “Successful” vaccination means people have antibodies against hepatitis B in the bloodstream – a sign that they’re protected against the disease.
One of the authors of the study, Ken C. Chiu, M.D., a professor of Clinical Diabetes, Endocrinology & Metabolism, is now at work on a new study to further investigate the potential link between the vaccine and diabetes resistance.
Doctors already knew of the association between diabetes and hepatitis B, a virus that infects the liver, and researchers have been exploring the possibility that diabetes might be triggered by bacteria, viruses or other disease-causing organisms. What’s important about this new study is that it shows just how vital this line of research may prove to be.